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Abstract The biological behavior of any tumor is the result of changes in gene expression caused 
by mutations accumulated in the carcinogenic process. In squamous carcinoma of the head and neck 
(SCCHN) there are numerous complex chromosome abnormalities. To make sense of this complexity 
it is necessary to identify the consistent chromosome changes in a large panel of tumors, to determine 
if these changes are true representations of the in vivo situation, and to construct a map of gene loci 
likely to be involved in the development and progression of cancer. Our findings indicate that cultured 
tumor cells are cytogenetically stable when compared to cells evolving in vivo. We also found that 
clues to the sequence of events in clonal evolution of individual tumors can be deduced by studying 
primary and metastatic tumors from the same patient, by examining separate clones within the same 
tumor, and by analyzing ploidy changes. Furthermore, comparison of the in vitro karyotypes to in situ 
analysis of the tumor tissue indicates that in vitro cultures are good representations of the in vivo 
tumor. We conclude that identification of consistent chromosome changes in cultured cells can lead 
to the loci of genes important in the clinical behavior of individual tumors. The most frequent 
chromosome abnormalities in SCCHN, found in 40-60% of tumors, are deletions affecting 3p, 5q, 8p, 
9p, and 18q. Less common consistent changes found in 3040% of tumors are gains affecting 3q, 5p, 
7p, Sq, and l l q .  Preliminary evidence suggests that loss of 18q may be prognostically important and 
may involve disruption of genes encoding cell adhesion molecules. 0 1993 Wiley-Liss, Inc. 
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We began our analysis of chromosome abnor- 
malities in squamous cell carcinoma (SCC) to 
identify the loci of genes likely to be involved in 
the development and progression of this tumor 
type. Our hypothesis was based on the same 
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= duplication; add = addition of unknown material; 
del = deletion. 
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premise as the early studies in leukemias and 
lymphomas, which postulated that consistent 
chromosome changes would lead to identifica- 
tion of genes important in the development and 
evolution of human cancers Ell. For example, 
the Philadelphia chromosome in chronic my- 
elogenous leukemia was shown to be a t(9;22) 
translocation, and led to the identification of 
the bcrlabl fusion product that activates the 
c-abl protein kinase [241. Similarly the t(8;14) 
translocation in Burkitt's lymphoma 151 led to 
the understanding that a chromosome rear- 
rangement could cause inappropriate expression 
of a regulatory gene and uncontrolled cell 
growth by bringing the promoter and enhancer 
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elements of an active gene (such as the immu- 
noglobulin genes in the B-cell lineage) into close 
proximity with c-myc [6].  Similarly, many other 
consistent rearrangements have provided bio- 
markers useful in classification and prognosis of 
individual tumors. Among these is one that is 
quite relevant to  the question of chemopreven- 
tion. The t(15,17) rearrangement characteristic 
of promyelocytic leukemia involves the first 
intron of the retinoic acid receptor, FUR-a [71. 
This is intriguing since this form of leukemia 
has been responsive t o  treatment with retinoids 
[8] .  As these examples show, knowledge of con- 
sistent chromosome changes in tumors can lead 
to  a better understanding of the mechanisms of 
cancer development and may provide the basis 
for novel therapies. 
ID ENTl FYI NG CONSISTENT CHROMOSOME 
CHANGES IN HEAD AND NECK CANCER 
Before we began our studies it was clear that 
the task of defining consistent chromosome 
abnormalities in SCC would be more difficult 
than in leukemia because the chromosome ab- 
normalities were more complex and numerous, 
and there was the added difficulty of obtaining 
metaphase spreads from solid tumors. In our 
favor was our experience in culturing squamous 
cancers, the large panel of squamous cancer 
lines we had already developed from patients 
treated in our clinics, and our experience in 
clinical cytogenetics. The cultured cells made it 
possible to  obtain multiple metaphase spreads 
and long prometaphase chromosomes so that 
the banding patterns in enough copies of each 
rearrangement could be fully analyzed. In this 
way we could identify nearly all chromosome 
rearrangements in each tumor for which cell 
culture was successful. 
Analysis of established cell lines clearly 
showed ways in which squamous cancers differ 
from leukemias and lymphomas. SCCs have few 
balanced chromosome translocations and few 
consistent translocations. Instead, there are 
frequent, complex translocations, many involv- 
ing multiple chromosomes. These complex rear- 
rangements often result in chromosome seg- 
ment losses, which are the most common chang- 
es in squamous cancers [91. The segmental 
losses are consistent among cell lines and tu- 
mors from different individuals, indicating that 
common genes are lost in the process of cancer 
progression. There are also a few consistent 
regions of segmental gains, as well as numerous 
breakpoints, many of which define the regions 
of losses and gains [9-111. 
Chromosome analysis of cell lines has been 
subject to  criticism. Many observers feel that 
cell lines do not represent the in uiuo situation; 
that tumor cell lines are unstable i n  uitro and 
are under strong selective pressure to  overcome 
the rigors of growth in an unnatural environ- 
ment by constantly evolving. Although based 
more on belief than on data, these are valid 
concerns that require analysis before drawing 
conclusions about the significance of consistent 
chromosome changes present in cultured cell 
lines. Therefore three testable questions were 
addressed. First, are squamous carcinoma cells 
karyotypically stable in uitro? Second, are the 
changes identified in culture also present i n  
uiuo, or  do these represent adaptations to  selec- 
tive pressures in uitro? Third, do the cells that 
grow i n  uitro represent the tumor stem line 
that persists in uiuo? Answering these questions 
using cytogenetic analysis would provide us 
with new biomarkers for predicting outcome as 
well as a much-needed map to  genes that deter- 
mine the biological behavior of individual hu- 
man cancers. 
KARYOTYPIC STABILITY OF SQUAMOUS 
CARCINOMA CELLS IN VITRO 
Several approaches were employed to  address 
the question of in uitro karyotype stability: 
analyzing the same cell lines over numerous in 
uitro passages t o  identify the frequency of kary- 
otypic changes with time; analyzing mitotic cells 
in fresh tumor tissue by the use of direct prepa- 
rations without intervening culture; and exam- 
ining fresh tumor cultures by in situ analysis on 
coverslips to  compare the first in uitro mitoses 
to those found in direct preparations versus 
those found after days, weeks, and months of i n  
uitro cultivation. 
The UM-SCC-17A, UM-SCC-17A subline, and 
UM-SCC- 17B cell lines were established from a 
patient who presented with early stage SCC of 
the larynx which was treated initially by radia- 
tion. Her tumor progressed during radiation 
and we received two specimens at the time of 
laryngectomy. The 17A cell line contained two 
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stable and closely related clones that grew from 
the primary tumor specimen; the 17B cell line 
was from tumor tissue that had spread outside 
the larynx into the soft tissue of the neck. 
These cell lines were each karyotyped in multi- 
ple passages ranging from 8 to 96 [12]. The 
consensus karyotype of each cell line was de- 
fined as the most consistent chromosome pre- 
sentation in multiple cells, discounting random 
losses or gains of individual chromosomes. The 
consensus karyotype of each of the three sub- 
lines was found to  be same in all passages ana- 
lyzed with the exception of passage 56 of UM- 
SCC-l7B, where 5 cells were found with a di- 
centric (dic)(7)(q11.2) replacing a normal 7. In 
passage 96 of this line, all cells examined had 
the dic(7). This represents a single in uitro 
change in three sublines carried over an aggre- 
gate of 270 passages spanning a period of more 
than one year and > 1350 population doublings. 
These findings indicated that SCC cell lines are 
generally stable in uitro, but left open the possi- 
bility that we had examined the cells after the 
most rigorous in uitro selection had taken place 
during the earliest culture history. It was there- 
fore important to  examine tumors at the earli- 
est possible stage in uitro and at intervals there- 
after if we were to  gain a sense of the effects of 
early evolutionary pressures i n  uitro. 
In Vifro Cultures Represent the 
In Viwo Tumor 
Among the 29 head and neck squamous carci- 
nomas we have fully analyzed, 1/3 were studied 
as established cell lines, 1/3 were studied as 
Fig. 1. Karyotype of UM-SCC-XP-1, subclone 1. 45,XY, 4, t(5;7)(ql1.2;~22), i(9p), i(9q). This cell is from 
a primary harvest (passage 0) of the fragment 1 culture. Reproduced from Worsham et a/. [15] with 
permission of the publisher. 
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direct preparations or early harvests, and 113 
were analyzed both in directlearly harvests and 
as established cell lines [Van Dyke, submitted]. 
These analyses indicate that the same cells that 
survive in long term culture are representative 
of dividing cells found in the tumors when they 
are removed from the patients. We previously 
reported similar observations for SCC of the 
vulva [ 10,111, and endometrial carcinomas [ 13, 
141. 
One particularly instructive head and neck 
cancer case we recently analyzed is the HFH- 
SCC-XP-1 tumor [15]. This squamous carcino- 
ma was analyzed in direct preparations, in situ 
preparations, early harvests, and multiple in  
vitro passages from separate fragments of tu- 
mor that were cultured and maintained as 
though they were from different tumors. Three 
closely related tumor clones were found. The 
HFH-SCC-XP-1 cell lines were characterized by 
monosomy 4, and iso(9p), iso(9q) as early 
changes shared by all three subclones. Other 
changes were superimposed on this background, 
giving rise to  three closely related subclones. 
Subclone 1 was characterized by a t(5;7) bal- 
anced translocation (Fig. l); subclones 2 and 3 
both contained monosomy 21 and were distin- 
guished from each other by a der(ll)t(lO;ll) 
(Fig. 2) in subclone 2 and a der(14)t(13;14) in 
subclone 3 (Fig. 3). This tumor existed in both 
diploid and tetraploid versions in uitro. To eval- 
uate the clonal evolution of this tumor, we used 
Fig. 2. Karyotype of UM-SCC-XP-1, subclone 2.44,XY, 4, i(9p), i(9q), der(1 l)t(10;1 l)(q21;p14), -21. This 
metaphase cell was from fragment 1,  passage 0. Monosomy 16 was present as a random loss in this cell 
only. Reproduced from Worsham et a/. [I51 with permission of the publisher. 
Chromosomal Biomarkers in Head and Neck Cancer 21 7 
these clonal rearrangements and ploidy changes 
together with the information we obtained by 
cultivating several tumor fragments as though 
they were separate tumors. 
A flow chart showing all of the karyotyped 
cells and their relationship to the karyotypic 
evolution of the primary tumor is shown in 
Figure4. The number of cells we karyotyped 
from each of four tumor fragments is indicated 
in the small squares in the bottom half of the 
figure. Fragments 1, 2 and 3 were each studied 
in several culture passages, as indicated on the 
left side of the figure. Fragment 4 was analyzed 
by direct preparation only; two intact mitotic 
cells were recovered from this procedure. Re- 
sults from each fragment are separated by 
dashed horizontal lines. The vertical lines join 
cells with the same chromosome composition to 
a circle at the top of the figure where the chro- 
mosome makeup of each cell, and its position in 
the proposed clonal evolution is indicated. Cells 
which are postulated to exist as intermediates 
in the clonal evolution, but for which we did not 
recover an example, are indicated by a broken 
circle, and cells for which karyotypes have been 
examined are shown as solid circles. We postu- 
late that the original event began in a normal 
cell with a 46,XY karyotype. The earliest karyo- 
typic events we could document were loss of 4 
and formation of the iso(9p), iso(9q) chromo- 
some markers, on which were superimposed 
either the t(5;7) or  loss of 21 plus either the 
der(l4) or the der(l1). Starting from the top left 
of the figure we can trace the evolution of sub- 
Fig. 3. Karyotype of UM-SCC-XP-1, subclone 3. 87,XXY, -4, 4, i(9p), i(9p), i(9q), i(gq), der(l4)t(l3;14)- 
(q21 ;p32)x2, -21, -21. This metaphase cell was from fragment 1, passage 0. Reproduced from Worsham 
e ta / .  [15] with permission of the publisher. 
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Fig. 4. Proposed clonal evolution of HFH-SCC-XP-1 from a common progenitor cell. The most likely clonal 
evolution is shown above the solid line. "T" refers to a tetraploidization, endoreduplication, or cell fusion 
event. Numbers within circles represent the chromosome number. Dotted circles represent probable 
karyotypic intermediates that were not actually seen. Solid circles represent cells or clones that were 
identified in culture. Vertical lines connect circles to squares that contain the number of cells analyzed 
from each passage with the karyotype indicated by the circle. Reproduced from Worsham eta/. [15] with 
permission of the publisher. 
clone 1. We found 6 cells that had only 4, 
iso(9p), iso(9q), plus t(5;7) in the karyotype. 
This karyotype, 45,XY,4,t(5;7)(q11.2;~22), 
iso(9p), iso(9q), is the primary karyotype of sub- 
clone 1. One cell from tumor fragment 4 was 
analyzed as a direct preparation. Since it was 
undergoing mitosis in the tumor, it cannot 
represent an artifact of culture. Five other cells 
with the same karyotype were observed in the 
fragment 2 culture during a passage 1 harvest. 
Subclone 1 underwent additional changes that 
began with tetraploidization. The tetraploid 
version of subclone 1 was observed in one cell 
from the direct preparation of fragment 4, indi- 
cating that tetraploidy was also an in uiuo oc- 
currence. Multiple tetraploid cells of this lineage 
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were also present in cultures from fragments 1 
and 2, including 18 cells characterized at pas- 
sage 4 in the fragment 1 culture. The tetraploid 
cells continued to evolve further by loss of extra 
copies of uninvolved chromosomes. Cells with 
84, 81 and 82 chromosomes were recovered 
from fragment 3 cultures. It is not possible to 
determine if these losses were present in uiuo or 
if these occurred i n  uitro. 
Subclones 2 and 3 were detected in the cul- 
tures from fragments l and 2. These subclones 
also existed as both diploid and tetraploid ver- 
sions. The diploid versions of subclones 2 and 3 
were more prominent in early culture, i.e., pas- 
sage 0 and 1, whereas the tetraploid versions 
were more prevalent in passage 2 and higher. 
Subclone 2 behaved like subclone 1 after tetra- 
ploidization and lost chromosomes; cells with 
88, 84, 82, 77 and 76 chromosomes were all 
recovered in various harvests from fragment 1 
and 2 cultures. In contrast, subclone 3 was rela- 
tively stable as a tetraploid population; numer- 
ous cells with 88 chromosomes were found in 
several passages. Subclone 3 also gave rise to 
one additional subclone that was characterized 
by an l l q + .  
These observations support the concept that 
the cells we study as i n  uitro cell lines are rep- 
resentative of the in uiuo tumors. The clones we 
detected in the earliest in uitro harvests were 
also represented after days and weeks in cul- 
ture. Such analysis also helps us to order the 
events that occur in tumor evolution. For exam- 
ple, specific chromosome losses (4, -9, -21) and 
rearrangements were early events, whereas 
tetraploidization came later. Figure 3 shows a 
cell with the tetraploid version of subclone 3. 
Note that chromosome 4, the isochromosome 9s, 
the der(l4), and chromosome 21 are all present 
as 2 copies; thus each chromosome was present 
as a single copy before the cell doubled its com- 
plement. 
We can be reasonably sure that both initial 
chromosome losses and rearrangements and 
tetraploidy were in uiuo events because we 
found dividing cells with these changes in the 
direct preparation and in primary culture. Nev- 
ertheless, it is important to confirm by other 
approaches that the chromosome changes were 
present in uiuo. We applied fluorescence in situ 
hybridization, a powerful new technique in this 
case. By using specific probes for chromosomes 
4, 17 and the X chromosome, we were able to 
show that the tumor tissue contained cells with 
a single signal for chromosome 4, two for 17, 
and 1 for X as expected in the diploid version of 
this tumor. We also found tumor populations 
with 2 signals for 4 and X and 4 signals for 17, 
indicating that the tumor had become tetraploid 
i n  uiuo and not in uitro. We conclude that what 
we see in in uitro culture is a good representa- 
tion of what has occurred in uiuo. The loss of 
extra copies of uninvolved chromosomes that 
occurs after tetraploidy is also a common event; 
many squamous carcinomas have chromosome 
counts or DNA content that fall in the hypotet- 
raploid to triploid range [9-111. This apparently 
random loss of supernumerary chromosomes 
makes sense; chromosomes not involved in 
cancer development most likely do not confer a 
selective advantage to the cell and may even 
hinder cell growth by increasing the require- 
ment for additional DNA synthesis. 
IN VITRO CULTURES AND THE IN VIVO 
TUMOR STEM LINE 
We also asked whether cells that grow out in 
uitro are representative of cells that proliferate 
as the tumor stem line in uiuo. This question 
can be addressed in part by analysis of cell lines 
established from both primary and recurrent or 
metastatic tumors from the same patient. We 
already described the UM-SCC-17A and 17B cell 
lines, separately derived from the primary site 
and from a metastatic tumor in the same pa- 
tient at the time of laryngectomy. Although 
these cells were very stable in uitro, there were 
numerous differences that distinguished the two 
cell lines, indicating that substantial in uiuo 
evolution had occurred independently in each 
clone. Nevertheless, each line contained 5 iden- 
tical changes that we consider to  be relatively 
early events in this tumor. This is shown sche- 
matically in Figure 5, where all changes in UM- 
SCC-17A are shown on the left and all changes 
in UM-SCC-17B are shown on the right. Clearly 
the two stemlines diverged substantially from 
one another i n  uiuo, but when placed in culture, 
each was like a snapshot of the tumor at the 
time of surgery. Comparing the changes com- 
mon to both lines makes it possible t o  see which 
events had occurred by the time the lines be- 
came separate clones. 
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Fig. 5. Postulated sequence of chromosome changes that occurred during the development and 
progression of the UM-SCC-17 tumor. Reproduced from Carey eta/., [I21 with permission of the publisher. 
This same type of comparison can be made 
with other cell lines from primary and metastat- 
ic tumors from the same patient. In the case of 
the UM-SCC-21A and 21B cell lines, the first 
specimen came from a tumor which persisted at 
the primary site after several resections and 
radiation treatment failures. The second speci- 
men came from a metastatic tumor in the sub- 
mandibular gland that was removed 14 months 
later. This case provided us with insight into 
the degree of change that occurs in the tumor 
stem line in uiuo. Several characteristic and 
distinctive chromosome changes were common 
to  both the primary and metastatic tumor. 
These are shown in the first column of Table I. 
In addition, each cell line contained unique 
changes (shown in columns 2 and 3), indicating 
that significant changes occurred in both tu- 
mors. The two clones must have diverged well 
before the surgery from which the first speci- 
men was received; the metastatic cells must 
have already left the primary site while it was 
still being treated. Nevertheless, the initial 
changes common to  both the primary and meta- 
static stemlines were recovered in both in uitro 
cell lines showing that the cultured cells repre- 
sent cells that persist in uiuo. 
The analysis of these three tumor systems, 
UM-SCC-2lA and 21B, as well as others [9,10], 
illustrate karyotypic evolution with tumor pro- 
gression. All indicate that evolution i n  uiuo is 
greater than that which occurs i n  uitro, and 
each supports the concept that cells which grow 
out in culture represent the stage of tumor 
evolution at the time the specimen is removed. 
UM-SCC-17A and 17B, HFH-SCC-XP1, and 
Consistent Chromosome Changes in 
Squamous Carcinomas of the Head 
and Neck 
In leukemias and lymphomas, analysis of both 
fresh leukemic cells and of leukemic cell lines 
demonstrates the same consistent chromosomal 
markers [2,3,5,71. Based on the data briefly 
reviewed above, we conclude that the chromo- 
some changes we have documented in our com- 
piled series of 29 head and neck tumors are 
likewise representative of the consistent chang- 
es that characterize human head and neck can- 
cers i n  uiuo. Now the question arises: are any of 
these consistent changes useful as predictive 
markers? In compiling our data we observed 
that one change, loss of 18q, is not only a very 
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TABLE I. Karyotypic Evolution of UM-SCC-21A and 21B 
Unique Chromosome Rearrangements 
UM-SCC -2 1A UM-SCC-21B Chromosome Rearrangements 
Common to Both Tumors (Primary tumor) (Metastatic tumor) 
der(13)i(13q)de1(13) 
(13qte1-11.2:: 















frequent event [ 161 but it is also more frequent- 
ly present in tumors from patients who have 
died of their disease than it is in those from 
patients who are alive and well. We first noticed 
loss of 18q as a possible marker of aggressive 
squamous cancers in our analysis of vulvar 
carcinomas [10,11]. Of six patients we studied, 
there were numerous consistent chromosome 
changes. Among the common abnormalities 
there were two segmental losses, 10q23-q25 and 
18q22-q23, that occurred in all 4 of the patients 
who died of their disease but did not occur in 
two patients who remain alive and well [lo]. 
Although the numbers are very small, this ob- 
servation alerted us to the possibility that one 
or both of these chromosome abnormalities 
might be associated with poor prognosis. In the 
SCCHN tumors analyzed thus far, loss of 
18q22-q23 has been noted in more than half of 
the cases (15/29). Of the patients whose tumors 
exhibited loss of 18q, more than 90% (14/15) 
have died. In contrast, of the patients whose 
tumors did not exhibit loss of 18q, only 28% 
(4/14) have died. These findings are provocative 
and suggest that a gene or set of genes that 
contribute to the malignant behavior of SCC 
may be located in this region. Clearly, prospec- 
tive analysis of 18q loss as a prognostic indica- 
tor is necessary, as is further work to identify 
the important genes in this region. The deleted 
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in colon cancer (DCC) gene [171 has been a 
valuable marker for analyzing loss of 18q [161, 
but thus far we have no evidence that this gene 
is expressed in normal squamous epithelium. In 
any case, it serves as a probe for examining loss 
of this region in fresh tumors and may there- 
fore serve as a good biomarker of highly aggres- 
sive neoplasms. 
Of special interest for tumors of the squa- 
mous epithelia are the recent observations that 
the desmoglein 1 andpemphigus vulgaris genes 
are both on chromosome 18 [ 181. These proteins 
are components of the desmosomes, special 
structures that form intracellular connections 
between squamous epithelial cells. Loss of func- 
tion of either of these genes in squamous tu- 
mors could lead to increased metastatic behav- 
ior by reducing cell-to-cell interaction. 
In summary, we have shown how early and 
established cultures can be used t o  define the 
recurrent chromosome changes in SCCHN. 
Changes found in vitro correspond to  in vivo 
changes. Certain of these chromosome abnor- 
malities may serve as biomarkers of aggressive 
behavior, and may be useful in screening early 
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